Zeman W, Shidnia H
J Neurol. 1976 Apr 23;212(2):107-15. doi: 10.1007/BF00329153.
The introduction of the concept of Nominal Standard Dose and of Time, Dose Fractionation Factors ostensibly permits definition of tolerance doses for normal tissues in unequivocal terms. However, even with these refinements, tolerance doses remain, at best, guidelines, because radiobiologic effectiveness is governed not only by the effective dose, but also by individual factors, which will modify the response. Attention must be accorded to these biologic parameters, in order to prevent injury to healthy tissues. Of particular significance are the relative size or volume of the irradiated tissue, the possible presence of co-existing pathology in the exposed organ and the development of disease after tge termination of the treatment. Even if these factors are properly respected, the risk of radiation injury cannot entirely be eliminated. The radiotherapist is therefore obligated to use an approach which minimizes the exposure of the healthy nervous tissue, a goal which has become attainable with the advent of modern accelerators as radiation sources.
名义标准剂量和时间、剂量分割因子概念的引入表面上使得能够明确界定正常组织的耐受剂量。然而,即便有了这些改进,耐受剂量充其量仍只是指导原则,因为放射生物学效应不仅取决于有效剂量,还受个体因素影响,这些因素会改变反应。必须关注这些生物学参数,以防止对健康组织造成损伤。尤其重要的是受照射组织的相对大小或体积、受照器官中可能并存的病理状况以及治疗结束后疾病的发展。即便这些因素都得到妥善考虑,辐射损伤的风险也无法完全消除。因此,放射治疗师有责任采用一种方法,尽量减少健康神经组织的受照剂量,随着现代加速器作为辐射源的出现,这一目标已变得可以实现。